TSXV:BTI.H - Post by User
Post by
prophetoffactzon Dec 16, 2022 2:51pm
130 Views
Post# 35176506
Glioblastoma market US$4.2 billion in 2028
Glioblastoma market US$4.2 billion in 2028BTI's presentation says US$2.14 billion in 2020 growing at 8.8 through 2028.
That's US$4.2 billion per year in 2028.
Not bad for a lead asset that is already in clinical trials with safety risk potentially well addressed already and efficacy data from other preclinical and clinical trials to build upon.
That's a C$5.67 billion market in 2028 in Canadian dollars.
BTI may be merging with another undervalued assets reducing dilution.
Then there is the EGF assets too, etc.